Clinical trials
Phase 2 Lymphoma, T-Cell, Peripheral trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Acrotech Biopharma Inc. | 1 |
| Affimed GmbH | 1 |
| AstraZeneca | 1 |
| BeiGene | 1 |
| Daiichi Sankyo | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 15 |
| Recurrence | 6 |
| Immunoblastic Lymphadenopathy | 4 |
| Lymphoma, Extranodal NK-T-Cell | 4 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
| Lymphoma, T-Cell | 4 |
| Lymphoma, T-Cell, Cutaneous | 4 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Burkitt Lymphoma | 3 |
| Dendritic Cell Sarcoma, Interdigitating | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.